Cervical cancer is the fourth most common cancer amongst women worldwide. The first line treatments for cancer involve surgery, chemotherapy and radiation which although can be moderately successful, results in a number of undesirable side effects and higher chances of relapsing due to resistance. Drug repurposing requires minimal costs and resources compared to new drug development. The use of already established drugs as opposed to chemotherapy and radiation results in minimal side effects and if successful, a relatively low incidence of relapse. A natural terpene-based compound namely Artemisinin, in its semisynthetic form known as Artesunate, originally used against Malaria has been identified to be involved in several modes of action against cancer, specifically on the Hippo Signalling Pathway; a critical pathway which controls cell proliferation, apoptosis and organ growth. The aim of this project is to evaluate the anticancer properties of Artesunate, alone or in combination with cisplatin; a chemotherapy drug.
I am a research Master's student currently at Kingston University, London, originally from Sri Lanka. I graduated with a first-class BSc in Biomedical Science in 2023. My keen interest in cellular biology led me to pursuing a Master's degree in Cancer Research with a focus on treatment with Dr Nadine Wehida and Dr Ahmed Elbediwy, both with a firm interest in cancer biology and drug treatment. I spend my spare time away from research going to the gym to increase my endurance, strength and coordination subsequently increasing energy levels and alleviating stress. My future career aspirations will undoubtedly be to pursue a PhD in cancer research, specifically on treatment by focusing on signalling pathways.